|
ERAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.311200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.343400E-01 |
| Normal-vs-Stage2 |
9.634000E-01 |
| Normal-vs-Stage3 |
6.456400E-01 |
| Normal-vs-Stage4 |
7.918600E-01 |
| Stage1-vs-Stage2 |
3.555400E-01 |
| Stage1-vs-Stage3 |
1.858780E-01 |
| Stage1-vs-Stage4 |
8.290200E-01 |
| Stage2-vs-Stage3 |
6.824800E-01 |
| Stage2-vs-Stage4 |
7.936400E-01 |
| Stage3-vs-Stage4 |
6.032200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.385800E-01 |
| Normal-vs-AfricanAmerican |
8.982000E-01 |
| Normal-vs-Asian |
5.378200E-01 |
| Caucasian-vs-AfricanAmerican |
1.919190E-01 |
| Caucasian-vs-Asian |
3.832400E-01 |
| AfricanAmerican-vs-Asian |
6.804800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.163800E-01 |
| Normal-vs-Female |
3.793000E-01 |
| Male-vs-Female |
1.679630E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.286200E-01 |
| Normal-vs-Extreme_Weight |
1.530830E-01 |
| Normal-vs-Obese |
7.926800E-01 |
| Normal-vs-Extreme_Obese |
6.934100E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.166600E-01 |
| Normal_Weight-vs-Obese |
4.251200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.105400E-01 |
| Extreme_Weight-vs-Obese |
1.709780E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.814200E-01 |
| Obese-vs-Extreme_Obese |
1.729200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.127200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.021400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.882400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.206100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.962400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.315800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.341900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.441500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.116300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.233200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.623600E-01 |
| Normal-VS-Type2 PRCC |
2.618600E-01 |
| Normal-VS-KIRP CIMP |
1.170400E-01 |
| Normal-VS-Unclassified PRCC |
1.632430E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.070600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.706400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.599740E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.346200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.894260E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.520800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.723400E-01 |
| Normal-vs-N1 |
4.809800E-01 |
| Normal-vs-N2 |
4.142000E-01 |
| N0-vs-N1 |
3.021600E-01 |
| N0-vs-N2 |
4.992400E-01 |
| N1-vs-N2 |
8.582800E-01 |
|
|
